Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Biogen Inc. BIIB

Set alert

Price alert · BIIB

All alert types
249.01 USD -4.61 -1.82%

At close · Nov 2

249.01 0.00 0.00%

After hours · Nov 2, 4:00 PM ET

Bid
248.96 × 1
Ask
249.00 × 1
247.91 Day range 255.53
149.33 52-week range 253.84
YTD
+41.49%
1 year
+61.41%
Open
253.81
Prev close
253.62
Mkt cap
36.81B
Vol
1.17M
Avg vol
1.04M
EPS
2.27
P/E
109.70
Div yield
0.00%
More statistics
Low
247.91
High
255.53
Forward P/E
15.29
Beta
0.09
Short ratio
4.46
Inst. own
99.78%
Dividend
0.00
Ex-div date
Earnings
Feb 5, 2027
50-d avg
227.08
200-d avg
201.18
1y target
264.23

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Feb 6, 2026Earnings: 1.99; estimate 1.63; surprise 22.09%
  • Nov 2, 2026Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 2, 2026Rating: Guggenheim · Buy → Buy
Signals (162)
NameDateAgo
SMA: BullishFeb 1, 20269 months ago
MACD: Buy SignalOct 1, 20251 year ago
SMA: BullishSep 1, 20251 year ago
RSI: OversoldDec 1, 20241 year ago
SMA: BearishJan 1, 20242 years ago
SMA: BullishDec 1, 20232 years ago
MACD: Sell SignalOct 1, 20233 years ago
SMA: BearishSep 1, 20233 years ago
SMA: BearishJun 1, 20233 years ago
MACD: Buy SignalOct 1, 20224 years ago
SMA: BullishSep 1, 20224 years ago
SMA: BullishSep 1, 20224 years ago
MACD: Sell SignalNov 1, 20215 years ago
SMA: BearishOct 1, 20215 years ago
SMA: BearishSep 1, 20215 years ago
SMA: BullishJun 1, 20215 years ago
SMA: BullishJun 1, 20215 years ago
MACD: Buy SignalJun 1, 20215 years ago
SMA: BearishApr 1, 20215 years ago
SMA: BearishApr 1, 20215 years ago

Newest 20 of 162.

Analyst view

Consensus: buy

Buy
Price target (mean) 264.23 +6.1% upside
Target (low)
175.00
Target (mean)
264.23
Target (high)
325.00
Ratings (0m) 36 25 buy · 10 hold · 1 sell
  • Strong buy4
  • Buy21
  • Hold10
  • Sell1
  • Strong sell0

Recommendation trend

  • This month 36
  • 1 month ago 35
  • 2 months ago 35

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

BIIB analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter2.852.45 – 3.871.99+43.3%2.58B+13.0%26
Next quarter3.552.93 – 4.043.57-0.6%2.61B+5.2%13
Current year12.5312.24 – 13.0715.28-18.0%10.53B+6.5%31
Next year16.2813.90 – 18.6712.53+30.0%10.75B+2.1%33

Upgrades and downgrades

The latest rating changes

BIIB analyst upgrades and downgrades
DateFirmActionFromTo
Nov 2, 2026GuggenheimMaintainedBuyBuy
Nov 2, 2026HC Wainwright & Co.MaintainedBuyBuy
Oct 29, 2026Canaccord GenuityMaintainedBuyBuy
Oct 29, 2026Argus ResearchUpgradeHoldBuy
Oct 29, 2026RBC CapitalMaintainedOutperformOutperform
Oct 29, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Oct 29, 2026UBSMaintainedBuyBuy
Oct 29, 2026TD CowenMaintainedBuyBuy
Oct 29, 2026WedbushMaintainedNeutralNeutral
Oct 29, 2026Truist SecuritiesReiteratedBuyBuy
Oct 29, 2026BairdMaintainedOutperformOutperform
Oct 29, 2026NeedhamMaintainedBuyBuy
Oct 28, 2026BarclaysMaintainedEqual-WeightEqual-Weight
Oct 22, 2026B of A SecuritiesMaintainedNeutralNeutral
Oct 21, 2026TD CowenMaintainedBuyBuy
Oct 20, 2026Wells FargoMaintainedOverweightOverweight
Oct 12, 2026JP MorganUpgradeNeutralOverweight
Oct 9, 2026UBSMaintainedBuyBuy
Oct 8, 2026RBC CapitalMaintainedOutperformOutperform
Sep 10, 2026HSBCMaintainedReduceReduce
Sep 3, 2026Piper SandlerReiteratedOverweightOverweight
Aug 25, 2026RBC CapitalMaintainedOutperformOutperform
Aug 13, 2026Wolfe ResearchUpgradePeer PerformOutperform
Aug 4, 2026MizuhoMaintainedOutperformOutperform
Aug 3, 2026CitigroupMaintainedNeutralNeutral
Jul 30, 2026UBSMaintainedBuyBuy
Jul 30, 2026HC Wainwright & Co.MaintainedBuyBuy
Jul 30, 2026Morgan StanleyMaintainedEqual-WeightEqual-Weight
Jul 30, 2026RBC CapitalMaintainedOutperformOutperform
Jul 30, 2026Canaccord GenuityMaintainedBuyBuy